Company news

Genetic Technologies Limited news in 2023

Genetic Technologies Limited's news releases, calls and decks from 2023, newest first.

View company

Update - Consolidation/Split - GTG

December 7, 2023

Updated Share Consolidation Timetable

December 6, 2023

2023 AGM Presentation

November 21, 2023

Consolidation/Split - GTG

November 21, 2023

Appendix 4C and Quarterly Activities Report - September 2023

October 29, 2023

GTG & Gold Coast Hospital Announce Precision Medicine Pilot

September 27, 2023

MRFF Grant Names GTG as Sole Industry Partner

September 11, 2023

geneType Granted Approval for 3 New Diseases in Australia

September 10, 2023

Annual Results Momentum Building on our Commercial Plans

August 30, 2023

2023 Annual Report and Appendix 4E

August 30, 2023

Updated Investor Presentation - August 2023

August 8, 2023

Appendix 4C and Quarterly Activities Report - June 2023

July 27, 2023

Publication Validates geneType for Melanoma Risk Assessment

April 27, 2023

Appendix 4C & Quarterly Activities Report - March 2023

April 26, 2023

Publication Validates geneType Prostate Cancer Risk Test

April 18, 2023

GeneType MultiTest Panel Expanded Inclusion of New Diseases

March 26, 2023

Further Study Validates geneType Breast Cancer Risk Test

March 12, 2023

Appendix 4D & Half-year Financial Report December 2022

February 26, 2023

Receipt of R&D Tax Incentive Refund for geneType Multi Test

February 16, 2023

Publication Highlights geneType Outperforms Current Models

February 8, 2023

Business Update - February 2023

February 8, 2023

Supplementary Announcement - Comprehensive Risk Test

February 6, 2023

Genetic Technologies Announces US$5M Registered Direct Offer

February 5, 2023

World First Comprehensive Risk Test-Breast & Ovarian Cancer

February 2, 2023

GTG to form Strategic Alliance with global leader QIAGEN

January 31, 2023

Appendix 4C and Quarterly Business Update December 2022

January 30, 2023

Colorectal Cancer Model Presented at ASCOGI Cancer Symposium

January 24, 2023

Decks in 2023